IMMUTEP LIMITED - AMER
2.0500
07-October-24 15:59:57
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
2.0200 - 2.0900
ISIN
N/A
Source
NASDAQ
-
17 Apr 2024 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Announces First Clinical Data from 90mg Dosing of Efti
05 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q2 FY24
30 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
21 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
07 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
22 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
09 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
06 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
03 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
-
Immutep to Participate in November Investor Events
02 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q1 FY24
31 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep receives ~A$1.13 million R&D Tax Incentive
25 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
24 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts at ESMO Congress 2023
16 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
03 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
21 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep to Participate in September Investor Conferences
05 Sep 2023 09:00:00 By Nasdaq GlobeNewswire
-
Immutep Receives Positive Scientific Advice from European Medicines Agency
01 Aug 2023 08:00:02 By Nasdaq GlobeNewswire